• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics

 

Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics


on

  • 825 views

ReaMetrix's regeant technology developed in the India

ReaMetrix's regeant technology developed in the India

Statistics

Views

Total Views
825
Views on SlideShare
825
Embed Views
0

Actions

Likes
0
Downloads
9
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics
 Towards 
Indigenously 
Developed,

 Locally 
Relevant,
Affordable 
Diagnosics
 Presentation Transcript

    • Towards
Indigenously
Developed,

 Locally
Relevant,
Affordable
Diagnos<cs

 The
Search
for
a
Sustainable
Model

 13th
September
2008
 © 2006 ReaMetrix, Inc. All rights reserved.
    • Disclosure
  
ReaMetrix
is
a
cross‐disciplinary
group
made
up
of
Biologists,
 Chemists,
Physicists
and

Engineers,
based
out
of
Bangalore
working
 towards
the
vision
of
affordable
diagnosHcs
of
relevance
to
the
 developing
world.
  
We
would
like
to
honestly
admit
that
all
pre‐conceived
ideas
with
 which
we
started
execuHng
on
our
vision
in
India,
turned
out
to
be
 totally
wrong.


  
This
has
forced
us
to
look
at
completely
new
paradigms
that
can
help
 build
a
sustainable
economic
model
to
solve
the
twin
issues
of
 accessibility
and
affordability
 © 2006 ReaMetrix, Inc. All rights reserved. Page 2
    • Framing
the
Big
Picture
  
DiagnosHcs
is
an
important
 component
in
disease
management.
  DiagnosHcs
is
all
about
“informaHon”
 generaHon:

InformaHon
is
generated
 to
help
the
physician
(and
in
some
 cases
the
paHents)
make
beSer
 clinical
decisions.
  DiagnosHcs
is
never
about
replacing
 the
doctor
or
a
replacement
of
the
 experience
garnered
in
a
local
context
 by
a
doctor
 © 2006 ReaMetrix, Inc. All rights reserved. Page 3
    • How
is
the
cost
of
diagnos<cs
influenced
in
different
contexts?
  In
most
developing
countries,
the
 diagnosHc
soluHons
used
are
parachuted
 from
resource‐rich
countries.
  During
development,
the
cost
economics
of
 these
soluHons
were
highly
influenced
by
 the
local
macroeconomic
environment
 prevailing
in
those
countries.
  
Design
criteria
opHmized
for
one
 environment
may
not
be
the
right
soluHon
 for
another.
 CANNOT
HAVE
A
ONE‐SIZE
 
 FITS
ALL
APPROACH
 © 2006 ReaMetrix, Inc. All rights reserved. Page 4
    • Different
priori<es
in
different
environments
  

In
the
developed
countries:
 •  Labor
costs
dominate
the
COGS.
 •  The
emphasis
is
on
reducHon
of
labor
 both
in
manufacturing
and
in
process.
 •  Less
emphasis
on
material
conservaHon.
  

In
the
resource‐poor
countries:
 •  Material
costs
dominate
the
COGS.
 •  The
emphasis
has
to
be
on
material
 recovery
–
more
of
the
raw
material
has
 to
end
up
in
finished
goods.
 •  Labor
component
has
a
small
contribuHon
 to
COGS.
 © 2006 ReaMetrix, Inc. All rights reserved. Page 5
    • An
Opportunity
to
Change
the
Paradigm?
  
Re‐Pose
the
problem
in
the
local
context
  
QuanHfy
the
cost
of
generaHng
clinical
informaHon
in
the
local
context
 
  
Define
“the
affordability
index”
in
the
context

of
local
macroeconomic
 environment
–
how
much
will
the
stakeholder
be
willing
to
pay?
  
Affordability
index
drives
the
appropriate
technology
that
can
deliver
 the
good
and
services
within
the
affordability
index.
 PRICE
DETERMINES
TECHNOLOGY,
TECHNOLOGY
DOESN’T
SET
THE
PRICE
 Pu#ng
this
Paradigm
to
Test
…..

 A
Case
Study
:

 An
Affordable
CD3/CD4
Diagnos@c
Test
in
Managing
HIV
Pa@ents
 © 2006 ReaMetrix, Inc. All rights reserved. Page 6
    • Case
Study:
Affordable
CD3/CD4
Diagnos<cs
  
Test
is
used
for
the
measurement
of
immune
system
T‐Cells
–
to
enable
a
 doctor
to
manage
HIV/AIDS
paHents
  
Disease
management
is
about
trends
–
not
decisions
based
on
a
single
point

 CD4 Count CD4 Count Rs.500 – Rs.1200 per test ? Cost per test Time Time © 2006 ReaMetrix, Inc. All rights reserved. Page 7
    • Anatomy
of
Clinical
Informa<on
Genera<on
in
the
Indian
Context
–
esp.
in
out
reach
centers
 Sample
journey
and
cost
accumulaHon
 Provide Acquire Transport Process Run Results Collection Centralized centre Path Lab Path Lab Doctor Hospital Layers of margin at every step © 2006 ReaMetrix, Inc. All rights reserved. Page 8
    • Issues
with
the
Current
Tes<ng
Methodology
 Technical



   
Aged
blood
samples
   
Accuracy
and
reliability
of
 Issues
with
CD3/CD4
Diagnos@cs 
 results
   
Time
lag
for
treatment
 decisions
   
Traceability
of
sample
 Lack
of
a
 Non‐local
 Non‐Local
 mechanism
to
 Manufacture
of
 Manufacture
of
 Commercial
 generate
clinical
 Instrumenta?on
 Reagents
:
 informa?on
 o@en
with
 Reliance
on
   
Encourages
too
many
layers
of
 closer
to
where
 features
with
 Imported
 margin
affecHng
affordability
 its
needed 
 minimal
 Reagents 
 relevance
in
the
   
Capital
costs
for
imported
 Indian
context
 equipments
act
as
big
barrier
to
 entry
as
well
as
in
adopHon
of
 closer
to
customer
models

 © 2006 ReaMetrix, Inc. All rights reserved. Page 9
    • A
Systems
Approach:
Reagents
+
Instrumenta<on
+
Delivery
 Reagents   
Strategy
:
Take
advantage
of
low
labor
cost
in
India
to
develop
reagents
locally
   
Focus
on
process
improvements
has
increased
material
yield
by
an
average
of
400%
‐
 higher
yield
results
in
lower

cost
of
a
test:
Rs
100
per
test
(nearly
5
fold
lower)
   
Lower
cost
reagents
BUT
with
the
same
quality
as
the
more
expensive
reagents
 imported
from
outside
India

 © 2006 ReaMetrix, Inc. All rights reserved. Page 10
    • A
Systems
Approach:
Reagents
+
Instrumenta<on
+
Delivery
 Reagents
:
Designing
Features
that
are
Locally
Relevant
 Concept
of
Uni<zed
Dried
Down
Reagents

 ‐ 

Reagents
require
no
cold‐chain
–
for
transport
as
well
as
for
storage
 ‐ 

Up
to
8
day
stability
of
stained‐fixed
samples
eliminaHng
blood
stability
issues
 associated
with
long
periods
of
transportaHon
from
collecHon
center
to
central
tesHng
 facility
 ‐ 

Reagents
can
withstand
extreme
heat
upto
45
C
 Dried
Reagents
are
not
a
significant
 need
in
the
western
context
…
but
are
 a
significant
boon
in
the
developing
 na?on
context
!
 Adv.
of
defining
the
problem
locally!
 © 2006 ReaMetrix, Inc. All rights reserved. Page 11
    • A
Systems
Approach:
Reagents
+
Instrumenta<on
+
Delivery
 • 
Ability
to
be
run
using
a
car
baSery
 • 
UniHzes
waste
disposal
–
minimizes
chance
of
 improper
waste
handling
 • 
Open
system
–
ability
to
port
mulHple
tests
 onto
the
system
–
It
is
NOT
an
instrument
for
 measuring
only
CD3/CD4
counts
 • 
Designed
to
withstand
harsh
environments
 • 
Portable
 • 
Reduced
Capital
Cost
 • 
Minimal
skill
level
needed
to
operate
 • 
Requires
no
field
calibraHon
 Uni@zed
Test
Cartridges 
 © 2006 ReaMetrix, Inc. All rights reserved. Page 12
    • A
Systems
Approach:
Reagents
+
Instrumenta<on
+
Delivery
 How
does
this
enable
a
new
paradigm
?
 • 

The
instrument
as
well
as
the
dried
down
reagents
enable
generaHon
of
 clinical
informaHon
closer
to
the
doctor‐paHent
interacHon
context,
that
is
 currently
not
possible:
 











‐


GP’s
Office
 











‐


Outreach
Centres
 











‐


ICU’s
in
Hospitals
 











‐


Mobile
screening
vans
 











‐


Ambulances
 *
Though
the
reagents
are
affordable
–
there
is
sHll
enough
margin
to
pay
for
 the
cost
of
the
instrument
as
well,
over
a
1‐year
period
 © 2006 ReaMetrix, Inc. All rights reserved. Page 13
    • A
Systems
Approach:
Reagents
+
Instrumenta<on
+
Delivery
 Enabling
Local
Economic
Ac<vity
and
Empowerment
of
 Health‐workers
by
Novel
Methods
of
Delivering
Clinical
 Informa<on
 Case
Study


:


SAANTWANAM



 (Work
being
carried
out
by
HAP
(hNp://www.hapindia.org/))
 © 2006 ReaMetrix, Inc. All rights reserved. Page 14
    • Saantwanam
 A
health
screening
project
in
Kerala
   FighHng
life
style
diseases
–
A
novel
project
by
HAP,
 Kutumbashree
&
State
Bank
of
India.
   ObjecHves
‐
Screening
for
Diabetes
mellitus,
obesity,
 hypertension
and
growth
retardaHon.
   Referral
to
physician
&
health
educaHon.
   Strategy
–
rely
on
locally
recruited
and
trained
young
women
 with
high
school
educaHon
but
from
poor
families
and
deploy
 them
to
accomplish
the
objecHve
of
wellness
management
 © 2006 ReaMetrix, Inc. All rights reserved. Page 15
    • The first batch © 2006 ReaMetrix, Inc. All rights reserved. Page 16
    • © 2006 ReaMetrix, Inc. All rights reserved. Page 17
    • Ques<ons
that
arise
from
these
case
studies
….
  
What
more
can
be
done
using
this
 model
of
healthcare
delivery?
  
How
do
we
combine
innovaHons
in
 reagent
design,
instrumentaHon
 design
and
delivery
to
impact
public
 health
especially
in
the
context
of
 the
underserved
?
  
How
can
we
extend
these
 innovaHons
to
bring
about
“wellness
 management”
rather
than
just
 stopping
at
“illness“
diagnosis
?










 © 2006 ReaMetrix, Inc. All rights reserved. Page 18
    • In
summary…
  
One
has
to
look
at
“diagnosHc
informaHon
 generaHon”
holisHcally,
not
just
as
a
set
of
 assay
reagents
and
hardware
planorms.
  
Addressing
“the
economics”
problem
 innovaHvely,
will
lead
to
sustainable
 soluHons.
  “Import
the
science”
but
not
the
 implementaHon
of
the
science
–
great
to
 think
globally
but
sustainable
innovaHon
is
 all
local.
  
Using
this
model,
one
can
not
only
 address
the
unmet
needs
in
resource‐poor
 seongs
but
change
the
way
diagnosHc
 informaHon
is
delivered
globally.
 © 2006 ReaMetrix, Inc. All rights reserved. Page 19
    • Thank You © 2006 ReaMetrix, Inc. All rights reserved. Page 20